Stage | Baseline CA72-4 levels | Post CA72-4 levels | P* | Decreased | P†| Decreased > 20% | P†|
---|---|---|---|---|---|---|---|
All patients | 2.99 (1.45, 8.64) | 2.92 (1.54, 7.12) | 0.801 | 272 (51.03) | 0.594 | 209 (39.21) | 0.592 |
0 | 2.12 (1.06, 5.07) | 2.03 (1.29, 3.71) | 0.951 | 16 (47.06) | Â | 14 (41.18) | Â |
I | 2.03 (1.26, 4.56) | 2.15 (1.33, 5.30) | 0.420 | 48 (46.60) | Â | 37 (35.92) | Â |
II | 2.84 (1.31, 7.62) | 2.92 (1.50, 6.91) | 0.566 | 80 (50.31) | Â | 58 (36.48) | Â |
III | 3.67 (1.96, 12.12) | 3.69 (1.64, 8.17) | 0.564 | 128 (54.01) | Â | 100 (42.19) | Â |